Menu
Back to Journals » Vascular Health and Risk Management » Volume 7
Antiplatelet combinations for prevention of atherothrombotic events
Authors Bollati M, Gaita F, Anselmino M
Published 12 January 2011 Volume 2011:7 Pages 23—30
DOI https://doi.org/10.2147/VHRM.S12271
Review by Single anonymous peer review
Peer reviewer comments 2
Mario Bollat,i Fiorenzo Gaita, Matteo Anselmino
Department of Internal Medicine, Division of Cardiology, University of Torino, Italy
Abstract: Antiplatelet therapy plays a fundamental role in reducing atherothrombotic events by several pathways. The present work reviews available evidence on antiplatelet therapy both for primary prevention and in the presence of established peripheral, cerebral, or cardiac ischemic disease. Due to the importance of adherence to therapy to achieve optimal effects, special attention is given to the use of fixed-dose oral formulations in the clinical subset of patients in whom double antiplatelet therapy has proven indications.
Keywords: aspirin, clopidogrel, ticlopidine, fixed-dose combinations
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.